NeuroSense Therapeutics L...

NASDAQ: NRSN · Real-Time Price · USD
1.20
0.03 (2.56%)
At close: Aug 15, 2025, 3:59 PM
1.20
0.42%
After-hours: Aug 15, 2025, 06:33 PM EDT

NeuroSense Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-10.21M -10.11M -12.34M -4.04M
Depreciation & Amortization
22K 21K 89K 3K
Stock-Based Compensation
557K 1.54M 5.11M 4.16M
Other Working Capital
-482K 928K 291K 289K
Other Non-Cash Items
277K -1.71M -1.19M 791K
Deferred Income Tax
n/a n/a n/a -2.72M
Change in Working Capital
-781K 1.91M 750K 273K
Operating Cash Flow
-10.13M -8.35M -7.59M -1.54M
Capital Expenditures
-3K -29K -70K -17K
Cash Acquisitions
n/a 3K n/a n/a
Purchase of Investments
n/a n/a -3.5M n/a
Sales Maturities Of Investments
n/a 3.5M n/a n/a
Other Investing Acitivies
4K -6K 29K n/a
Investing Cash Flow
1K 3.47M -3.54M -17K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-391K n/a 3.69M 2.04M
Financial Cash Flow
10.91M 3.98M 3.69M 11.9M
Net Cash Flow
738K -903K -7.52M 10.36M
Free Cash Flow
-10.14M -8.38M -7.66M -1.56M